Press Releases
September 10 2024
InMode Announces Share Repurchase Program of Up to 7.68 Million Shares
September 04 2024
InMode to Present at 2024 Baird Global Healthcare Conference
August 06 2024
InMode to Present at Upcoming Investor Conferences
August 01 2024
InMode Reports Q2 2024 Financial Results; Quarterly Revenue of $86.4M
July 31 2024
InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform
July 17 2024
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling
July 11 2024
InMode to Report Q2 2024 Financial Results and Hold Conference Call on Aug. 1, 2024
May 16 2024
InMode to Present at Jefferies Healthcare Conference
May 02 2024
InMode Reports Q1 2024 Financial Results
April 15 2024
InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL
